scispace - formally typeset
I

Inder M. Verma

Researcher at Salk Institute for Biological Studies

Publications -  13
Citations -  2707

Inder M. Verma is an academic researcher from Salk Institute for Biological Studies. The author has contributed to research in topics: Induced pluripotent stem cell & Neural stem cell. The author has an hindex of 9, co-authored 13 publications receiving 2445 citations.

Papers
More filters
Journal ArticleDOI

c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene

TL;DR: It is shown that normal cellular protein can induce transformation when expressed in an inappropriate cell type, and even though the c-fos protein is completely different from the v- fos protein at its C terminus, it is capable of transforming cultured fibroblasts.
Journal ArticleDOI

Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.

TL;DR: It is proposed that most differentiated cells in the CNS upon defined genetic alterations undergo dedifferentiation to generate a NSC or progenitor state to initiate and maintain the tumor progression, as well as to give rise to the heterogeneous populations observed in malignant gliomas.
Journal ArticleDOI

Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice

TL;DR: Using a combination of behavioural analysis of six inbred mouse strains with quantitative gene expression profiling of several brain regions, the identification of 17 genes with expression patterns that correlate with anxiety-like behavioural phenotypes are identified.
Journal Article

Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice

TL;DR: In this article, a combination of behavioural analysis of six inbred mouse strains with quantitative gene expression profiling of several brain regions was used to identify 17 genes with expression patterns that correlate with anxiety-like behavioural phenotypes.
Journal ArticleDOI

Dedifferentiation and reprogramming: origins of cancer stem cells

TL;DR: The similarities between tumor dedifferentiation and somatic cell reprogramming are discussed and how this may pose a risk to the application of this new technology in regenerative medicine.